awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36708942-3C113015-6E19-44E9-ACE6-C5BC831D3851
Q36708942-3C113015-6E19-44E9-ACE6-C5BC831D3851
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36708942-3C113015-6E19-44E9-ACE6-C5BC831D3851
Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia.
P50
Q36708942-3C113015-6E19-44E9-ACE6-C5BC831D3851
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36708942-3C113015-6E19-44E9-ACE6-C5BC831D3851
rank
NormalRank
type
BestRank
Statement
P1545
20
http://www.w3.org/2001/XMLSchema#string
P1932
Michele Cavo
http://www.w3.org/2001/XMLSchema#string
P50
Michele Cavo